← Back to Search

Hemostasis Device

Quikclot Radial Pad for Coronary Artery Disease

N/A

Waitlist Available

Led By Jonathan Roberts, MD

Research Sponsored by Memorial Healthcare System

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 3 hours

Awards & highlights

Study Summary

This trial is evaluating whether the QuikClot® Radial® pad is more effective than the TR Band® at achieving hemostasis (stopping bleeding) after a radial artery puncture (TRA).

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 3 hours

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~3 hours

This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 hours for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Initial successful hemostasis

Total Time to hemostasis

Secondary outcome measures

Radial Artery Occlusion

Trial Design

3Treatment groups

Experimental Treatment

Active Control

Group I: Arm 3Experimental Treatment1 Intervention

Quikclot Radial Pad with Tegaderm dressing to hold the pad in place

Group II: Arm 2Experimental Treatment1 Intervention

Quikclot Radial pad with Coban Bandage to hold the pad in place

Group III: Arm 1Active Control1 Intervention

Standard of Care (TR Band)

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Quikclot Radial Pad

2018

N/A

~300

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Memorial Healthcare SystemLead Sponsor

8 Previous Clinical Trials

985 Total Patients Enrolled

Z-MedicaIndustry Sponsor

1 Previous Clinical Trials

266 Total Patients Enrolled

Jonathan Roberts, MDPrincipal InvestigatorMemorial Healthcare System

3 Previous Clinical Trials

2,751 Total Patients Enrolled

1 Trials studying Coronary Artery Disease

100 Patients Enrolled for Coronary Artery Disease

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are additional enrollees being welcomed into this trial?

"Affirmative. Information on clinicaltrials.gov reveals that this medical experiment is currently recruiting individuals, with the initial posting taking place on August 1st 2018 and a recent update occurring in April 4th 2022. The study requires 300 subjects to be enrolled at one site."

Answered by AI

How many volunteers are being enrolled in this clinical experiment?

"Affirmative. Evidence present on clinicaltrials.gov attests to the fact that this research trial, which began enrolling patients since August 1st 2018, is still accepting participants. Approximately 300 volunteers have been requested from one specific site."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

QuikClot® Radial® Pad Versus TR Band® After Transradial Artery Access (TRA)

2018. "QuikClot® Radial® Pad Versus TR Band® After Transradial Artery Access (TRA)". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03535597.